Samuel C. Wadsworth
Chief Tech/Sci/R&D Officer bij ULTRAGENYX PHARMACEUTICAL INC.
Vermogen: - $ op 31-03-2024
Profiel
Samuel C.
Wadsworth is an Independent Director at Precision BioSciences, Inc. and the Chief Scientific Officer at Ultragenyx Pharmaceutical, Inc. He previously worked as the Director of Molecular Biology at Genzyme Corp.
from 2010 to 2013 and as the Chief Scientific Officer at Dimension Therapeutics, Inc. from 2013 to 2017.
Wadsworth also held a position as Principal at Sanofi-Aventis U.S.
LLC.
He earned a doctorate degree from The University of Chicago and an undergraduate degree from Southern Illinois University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-11-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Samuel C. Wadsworth
| Bedrijven | Functie | Begin |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | 01-11-2017 |
| PRECISION BIOSCIENCES, INC. | Director/Board Member | 06-11-2021 |
Eerdere bekende functies van Samuel C. Wadsworth
| Bedrijven | Functie | Einde |
|---|---|---|
| DIMENSION THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 01-11-2017 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-01-2013 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - |
Opleiding van Samuel C. Wadsworth
| The University of Chicago | Doctorate Degree |
| Southern Illinois University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PRECISION BIOSCIENCES, INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz in June 20, 2013 and is headquartered in Cambridge, MA. | Health Technology |
